NCT00149864View on ClinicalTrials.gov

Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A302

PHASE3CompletedINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Renal Transplant
Interventions
DRUG

Mycophenolate sodium (enteric coated)

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY